Federal Register (FR) Notices, April 9

Weekly Voice | Apr 7, 2021

Summary Excerpts from Select Federal Register Notices for CHPA Weekly Voice

Week of April 5, 2021

Rulemaking

FDA Electronic Import Entries; Technical Amendments; Final Rule

Rule effective: April 1, 2021

FDA Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs; Corrections; Final Rule; Correcting Amendments

Rule effective: April 1, 2021

Regulatory Information/Comment Opportunities

HHS Regulatory Agenda; Semiannual Regulatory Agenda

The Regulatory Flexibility Act of 1980 and Executive Order (EO) 12866 require the semiannual issuance of an inventory of rulemaking actions under development throughout the Department, offering for public review summarized information about forthcoming regulatory actions.

Non-FR Info

Medical Devices

Accelerating Medical Device Innovation with Regulatory Science Tools

Dietary Supplements

FDA Extends Flexibility for Unique Facility Identifier Requirement for Food Facility Registration through December 2022

Click here to view a select list of relevant Federal Register notices for the OTC, dietary supplement, and consumer medical device industries.